EUVIMEDScopri EUVIMED
Randomisierte kontrollierte StudieVergleichsstudieÄquivalenzstudieOpen access

Comparing Email Versus Text Messaging as Delivery Platforms for Supporting Patients With Major Depressive Disorder: Noninferiority Randomized Controlled Trial

Medard K Adu iD, Oghenekome Eboreime iD, Reham Shalaby iD, Ejemai Eboreime iD, Belinda Agyapong iD, Raquel da Luz Dias iD, Adegboyega O Sapara iD, Vincent I O Agyapong iD

JMIR Formative Research · 2024

DOI: 10.2196/59003 ↗

At a glance

Randomisierte kontrollierte Studie in JMIR Formative Research, 2024. Written by Medard K Adu and 7 co-authors. Institution: Department of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada. Major MEDLINE topics: Text Messaging, Major Depressive Disorder, Electronic Mail. 60 references. The full text is freely available in PubMed Central.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

The prevalence of major depressive disorder (MDD) poses significant global health challenges, with available treatments often insufficient in achieving remission for many patients. Digital health technologies, such as SMS text messaging–based cognitive behavioral therapy, offer accessible alternatives but may not reach all individuals. Email communication presents a secure avenue for health communication, yet its effectiveness compared to SMS text messaging in providing mental health support for patients with MDD remains uncertain.

Objective

This study aims to compare the efficacy of email versus SMS text messaging as delivery platforms for supporting patients with MDD, addressing a critical gap in understanding optimal digital interventions for mental health care.

Methods

A randomized noninferiority pilot trial was conducted, comparing outcomes for patients receiving 6-week daily supportive messages via email with those receiving messages via SMS text message. This duration corresponds to a minimum of 180 days of message delivery. The supportive messages maintained consistent length and structure across both delivery methods.

Participants

(N=66) were recruited from the Access 24/7 clinic in Edmonton, Alberta, among those who were diagnosed with MDD. The outcomes were measured at baseline and 6 months after enrollment using the Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder-7 (GAD-7), and the World Health Organization Well-Being Index (WHO-5).

Results

Most of the participants were females (n=43, 65%), aged between 26 and 40 years (n=34, 55%), had high school education (n=35, 58%), employed (n=33, 50%), and single (n=24, 36%). Again, most participants had had no history of any major physical illness (n=56, 85%) and (n=61, 92%) responded “No” to having a history of admission for treatment of mood disorders. There was no statistically significant difference in the mean changes in PHQ-9, GAD-7, and WHO-5 scores between the email and SMS text messaging groups (mean difference, 95% CI: –1.90, 95% CI –6.53 to 2.74; 5.78, 95% CI –1.94 to 13.50; and 11.85, 95% CI –3.81 to 27.51), respectively. Both supportive modalities showed potential in reducing depressive symptoms and improving quality of life.

Conclusions

The study’s findings suggest that both email and SMS text messaging interventions have equivalent effectiveness in reducing depression symptoms among individuals with MDD. As digital technology continues to evolve, harnessing the power of multiple digital platforms for mental health interventions can significantly contribute to bridging the existing treatment gaps and improving the overall well-being of individuals with depressive conditions. Further research is needed with a larger sample size to confirm and expand upon these findings. Trial Registration ClinicalTrials.gov NCT04638231; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552095/

Subjects

MeSH terms (MEDLINE)

Text MessagingMajor Depressive DisorderElectronic MailHumansFemaleMaleAdultMiddle AgedPilot Projects

Author keywords

SMS text messagingText4Supportcognitive behavioral therapycommunicationdepression symptomsdepressive disorderdigital healthdigital interventiondigital interventionseffectivenessemail messagingglobal healthhealth communicationmajor depressive disordermental health

Authors and institutions

  • Department of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada.
  • Reproductive Care Program, Healthy Population & Provincial Initiatives, IWK, Halifax, NS, Canada.
  • Department of Psychiatry, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.

ORCID profiles: Medard K Adu, Oghenekome Eboreime, Reham Shalaby, Ejemai Eboreime, Belinda Agyapong, Raquel da Luz Dias, Adegboyega O Sapara, Vincent I O Agyapong

Cite

APA

Adu, M. K., Eboreime, O., Shalaby, R., Eboreime, E., Agyapong, B., da Luz Dias, R., Sapara, A. O., & Agyapong, V. I. O. (2024). Comparing Email Versus Text Messaging as Delivery Platforms for Supporting Patients With Major Depressive Disorder: Noninferiority Randomized Controlled Trial. JMIR Formative Research. https://doi.org/10.2196/59003

Vancouver

Adu MK, Eboreime O, Shalaby R, Eboreime E, Agyapong B, da Luz Dias R, et al. Comparing Email Versus Text Messaging as Delivery Platforms for Supporting Patients With Major Depressive Disorder: Noninferiority Randomized Controlled Trial. JMIR Formative Research. 2024. doi:10.2196/59003

BibTeX
@article{Adu2024,
  author = {Adu, Medard K and Eboreime, Oghenekome and Shalaby, Reham and Eboreime, Ejemai and Agyapong, Belinda and da Luz Dias, Raquel and Sapara, Adegboyega O and Agyapong, Vincent I O},
  title = {Comparing Email Versus Text Messaging as Delivery Platforms for Supporting Patients With Major Depressive Disorder: Noninferiority Randomized Controlled Trial},
  journal = {JMIR Formative Research},
  year = {2024},
  doi = {10.2196/59003}
}
Start for free →